nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—XDH—Cisplatin—peripheral nervous system neoplasm	0.394	0.599	CbGbCtD
Deferoxamine—XDH—Doxorubicin—peripheral nervous system neoplasm	0.264	0.401	CbGbCtD
Deferoxamine—XDH—Effects of Nitric Oxide—MB—peripheral nervous system neoplasm	0.0212	0.851	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00197	0.0791	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000382	0.0153	CbGpPWpGaD
Deferoxamine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000285	0.000899	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000898	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.000893	CcSEcCtD
Deferoxamine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000282	0.000892	CcSEcCtD
Deferoxamine—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00028	0.000885	CcSEcCtD
Deferoxamine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000279	0.000881	CcSEcCtD
Deferoxamine—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000878	CcSEcCtD
Deferoxamine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000274	0.000866	CcSEcCtD
Deferoxamine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000274	0.000865	CcSEcCtD
Deferoxamine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000273	0.000862	CcSEcCtD
Deferoxamine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000273	0.000862	CcSEcCtD
Deferoxamine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000272	0.000859	CcSEcCtD
Deferoxamine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.000856	CcSEcCtD
Deferoxamine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000271	0.000855	CcSEcCtD
Deferoxamine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00027	0.000853	CcSEcCtD
Deferoxamine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000268	0.000848	CcSEcCtD
Deferoxamine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.000848	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000268	0.000847	CcSEcCtD
Deferoxamine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.000845	CcSEcCtD
Deferoxamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000267	0.000844	CcSEcCtD
Deferoxamine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000844	CcSEcCtD
Deferoxamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.000841	CcSEcCtD
Deferoxamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000265	0.000838	CcSEcCtD
Deferoxamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000265	0.000838	CcSEcCtD
Deferoxamine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.000837	CcSEcCtD
Deferoxamine—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000831	CcSEcCtD
Deferoxamine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000263	0.00083	CcSEcCtD
Deferoxamine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000263	0.00083	CcSEcCtD
Deferoxamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000262	0.000827	CcSEcCtD
Deferoxamine—Infection—Vincristine—peripheral nervous system neoplasm	0.000261	0.000825	CcSEcCtD
Deferoxamine—XDH—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000258	0.0104	CbGpPWpGaD
Deferoxamine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000258	0.000814	CcSEcCtD
Deferoxamine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000257	0.000813	CcSEcCtD
Deferoxamine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000812	CcSEcCtD
Deferoxamine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000257	0.000811	CcSEcCtD
Deferoxamine—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000806	CcSEcCtD
Deferoxamine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000255	0.000805	CcSEcCtD
Deferoxamine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.000805	CcSEcCtD
Deferoxamine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.000804	CcSEcCtD
Deferoxamine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000255	0.000804	CcSEcCtD
Deferoxamine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000252	0.000795	CcSEcCtD
Deferoxamine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000251	0.000794	CcSEcCtD
Deferoxamine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000793	CcSEcCtD
Deferoxamine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000251	0.000792	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.000785	CcSEcCtD
Deferoxamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000248	0.000784	CcSEcCtD
Deferoxamine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000247	0.000779	CcSEcCtD
Deferoxamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000246	0.000778	CcSEcCtD
Deferoxamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000246	0.000778	CcSEcCtD
Deferoxamine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000246	0.000776	CcSEcCtD
Deferoxamine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.000774	CcSEcCtD
Deferoxamine—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000769	CcSEcCtD
Deferoxamine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.000768	CcSEcCtD
Deferoxamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000243	0.000768	CcSEcCtD
Deferoxamine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000242	0.000766	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000241	0.000761	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000241	0.00076	CcSEcCtD
Deferoxamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00024	0.000758	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000239	0.000756	CcSEcCtD
Deferoxamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000238	0.000752	CcSEcCtD
Deferoxamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000238	0.000752	CcSEcCtD
Deferoxamine—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000746	CcSEcCtD
Deferoxamine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000236	0.000746	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.000744	CcSEcCtD
Deferoxamine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000234	0.000738	CcSEcCtD
Deferoxamine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.000737	CcSEcCtD
Deferoxamine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000233	0.000735	CcSEcCtD
Deferoxamine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000233	0.000735	CcSEcCtD
Deferoxamine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000232	0.000734	CcSEcCtD
Deferoxamine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000232	0.000734	CcSEcCtD
Deferoxamine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000733	CcSEcCtD
Deferoxamine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000231	0.000729	CcSEcCtD
Deferoxamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000231	0.000729	CcSEcCtD
Deferoxamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000229	0.000723	CcSEcCtD
Deferoxamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000229	0.000723	CcSEcCtD
Deferoxamine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000228	0.00072	CcSEcCtD
Deferoxamine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000719	CcSEcCtD
Deferoxamine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000719	CcSEcCtD
Deferoxamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000227	0.000718	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000227	0.000717	CcSEcCtD
Deferoxamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000227	0.000717	CcSEcCtD
Deferoxamine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000226	0.000714	CcSEcCtD
Deferoxamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000226	0.000714	CcSEcCtD
Deferoxamine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000226	0.000713	CcSEcCtD
Deferoxamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000225	0.000712	CcSEcCtD
Deferoxamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000225	0.000712	CcSEcCtD
Deferoxamine—Pain—Vincristine—peripheral nervous system neoplasm	0.000225	0.00071	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000223	0.000705	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000221	0.000697	CcSEcCtD
Deferoxamine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000217	0.000686	CcSEcCtD
Deferoxamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000217	0.000685	CcSEcCtD
Deferoxamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.000685	CcSEcCtD
Deferoxamine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.000681	CcSEcCtD
Deferoxamine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.000681	CcSEcCtD
Deferoxamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000216	0.000681	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000215	0.000679	CcSEcCtD
Deferoxamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000214	0.000675	CcSEcCtD
Deferoxamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000214	0.000675	CcSEcCtD
Deferoxamine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000213	0.000673	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000669	CcSEcCtD
Deferoxamine—Infection—Etoposide—peripheral nervous system neoplasm	0.000212	0.000668	CcSEcCtD
Deferoxamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000211	0.000667	CcSEcCtD
Deferoxamine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000665	CcSEcCtD
Deferoxamine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000663	CcSEcCtD
Deferoxamine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000209	0.000659	CcSEcCtD
Deferoxamine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000208	0.000659	CcSEcCtD
Deferoxamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000208	0.000656	CcSEcCtD
Deferoxamine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000656	CcSEcCtD
Deferoxamine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000208	0.000656	CcSEcCtD
Deferoxamine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000208	0.000656	CcSEcCtD
Deferoxamine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000207	0.000655	CcSEcCtD
Deferoxamine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000207	0.000653	CcSEcCtD
Deferoxamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000201	0.000636	CcSEcCtD
Deferoxamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.000635	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000201	0.000634	CcSEcCtD
Deferoxamine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000199	0.000629	CcSEcCtD
Deferoxamine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000199	0.000628	CcSEcCtD
Deferoxamine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00062	CcSEcCtD
Deferoxamine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000613	CcSEcCtD
Deferoxamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000194	0.000612	CcSEcCtD
Deferoxamine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00061	CcSEcCtD
Deferoxamine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000607	CcSEcCtD
Deferoxamine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000191	0.000604	CcSEcCtD
Deferoxamine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00019	0.0006	CcSEcCtD
Deferoxamine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000591	CcSEcCtD
Deferoxamine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000591	CcSEcCtD
Deferoxamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.000591	CcSEcCtD
Deferoxamine—XDH—Metabolism—GNS—peripheral nervous system neoplasm	0.000187	0.00749	CbGpPWpGaD
Deferoxamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.00059	CcSEcCtD
Deferoxamine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000581	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000184	0.000581	CcSEcCtD
Deferoxamine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000184	0.00058	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000579	CcSEcCtD
Deferoxamine—Pain—Etoposide—peripheral nervous system neoplasm	0.000182	0.000575	CcSEcCtD
Deferoxamine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000574	CcSEcCtD
Deferoxamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.00057	CcSEcCtD
Deferoxamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00018	0.000568	CcSEcCtD
Deferoxamine—XDH—Metabolism—NME1—peripheral nervous system neoplasm	0.000179	0.00718	CbGpPWpGaD
Deferoxamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000175	0.000552	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000174	0.00055	CcSEcCtD
Deferoxamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000174	0.000549	CcSEcCtD
Deferoxamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000548	CcSEcCtD
Deferoxamine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000547	CcSEcCtD
Deferoxamine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000547	CcSEcCtD
Deferoxamine—XDH—Metabolism—COX2—peripheral nervous system neoplasm	0.000172	0.00691	CbGpPWpGaD
Deferoxamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000541	CcSEcCtD
Deferoxamine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00054	CcSEcCtD
Deferoxamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.00054	CcSEcCtD
Deferoxamine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000538	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000536	CcSEcCtD
Deferoxamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000169	0.000534	CcSEcCtD
Deferoxamine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000168	0.000532	CcSEcCtD
Deferoxamine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000168	0.000532	CcSEcCtD
Deferoxamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000167	0.000528	CcSEcCtD
Deferoxamine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000524	CcSEcCtD
Deferoxamine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000521	CcSEcCtD
Deferoxamine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00052	CcSEcCtD
Deferoxamine—Headache—Vincristine—peripheral nervous system neoplasm	0.000165	0.00052	CcSEcCtD
Deferoxamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000512	CcSEcCtD
Deferoxamine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000511	CcSEcCtD
Deferoxamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000502	CcSEcCtD
Deferoxamine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.0005	CcSEcCtD
Deferoxamine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000496	CcSEcCtD
Deferoxamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000157	0.000496	CcSEcCtD
Deferoxamine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000495	CcSEcCtD
Deferoxamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000156	0.000493	CcSEcCtD
Deferoxamine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000485	CcSEcCtD
Deferoxamine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000483	CcSEcCtD
Deferoxamine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000481	CcSEcCtD
Deferoxamine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000481	CcSEcCtD
Deferoxamine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000479	CcSEcCtD
Deferoxamine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000478	CcSEcCtD
Deferoxamine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000151	0.000476	CcSEcCtD
Deferoxamine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000474	CcSEcCtD
Deferoxamine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000473	CcSEcCtD
Deferoxamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000467	CcSEcCtD
Deferoxamine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000462	CcSEcCtD
Deferoxamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000146	0.00046	CcSEcCtD
Deferoxamine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000459	CcSEcCtD
Deferoxamine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000458	CcSEcCtD
Deferoxamine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000446	CcSEcCtD
Deferoxamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000141	0.000445	CcSEcCtD
Deferoxamine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000444	CcSEcCtD
Deferoxamine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000444	CcSEcCtD
Deferoxamine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000443	CcSEcCtD
Deferoxamine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000439	CcSEcCtD
Deferoxamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000436	CcSEcCtD
Deferoxamine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000435	CcSEcCtD
Deferoxamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000135	0.000428	CcSEcCtD
Deferoxamine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000427	CcSEcCtD
Deferoxamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000133	0.000421	CcSEcCtD
Deferoxamine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000414	CcSEcCtD
Deferoxamine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000411	CcSEcCtD
Deferoxamine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000403	CcSEcCtD
Deferoxamine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000127	0.0004	CcSEcCtD
Deferoxamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000126	0.0004	CcSEcCtD
Deferoxamine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000393	CcSEcCtD
Deferoxamine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000393	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000391	CcSEcCtD
Deferoxamine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000383	CcSEcCtD
Deferoxamine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000377	CcSEcCtD
Deferoxamine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000377	CcSEcCtD
Deferoxamine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000375	CcSEcCtD
Deferoxamine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000371	CcSEcCtD
Deferoxamine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00037	CcSEcCtD
Deferoxamine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00037	CcSEcCtD
Deferoxamine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000369	CcSEcCtD
Deferoxamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000368	CcSEcCtD
Deferoxamine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000366	CcSEcCtD
Deferoxamine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000364	CcSEcCtD
Deferoxamine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000364	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000361	CcSEcCtD
Deferoxamine—XDH—Metabolism—ENO2—peripheral nervous system neoplasm	0.000113	0.00454	CbGpPWpGaD
Deferoxamine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000352	CcSEcCtD
Deferoxamine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000349	CcSEcCtD
Deferoxamine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000349	CcSEcCtD
Deferoxamine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000347	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000344	CcSEcCtD
Deferoxamine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000343	CcSEcCtD
Deferoxamine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000342	CcSEcCtD
Deferoxamine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000342	CcSEcCtD
Deferoxamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00034	CcSEcCtD
Deferoxamine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000339	CcSEcCtD
Deferoxamine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000339	CcSEcCtD
Deferoxamine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000336	CcSEcCtD
Deferoxamine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000326	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000326	CcSEcCtD
Deferoxamine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000322	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000318	CcSEcCtD
Deferoxamine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000313	CcSEcCtD
Deferoxamine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.000311	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000308	CcSEcCtD
Deferoxamine—XDH—Metabolism—BCHE—peripheral nervous system neoplasm	9.56e-05	0.00384	CbGpPWpGaD
Deferoxamine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000301	CcSEcCtD
Deferoxamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.0003	CcSEcCtD
Deferoxamine—Pain—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.000298	CcSEcCtD
Deferoxamine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.44e-05	0.000298	CcSEcCtD
Deferoxamine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.44e-05	0.000298	CcSEcCtD
Deferoxamine—XDH—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.12e-05	0.00366	CbGpPWpGaD
Deferoxamine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000285	CcSEcCtD
Deferoxamine—XDH—Metabolism—TH—peripheral nervous system neoplasm	8.99e-05	0.00361	CbGpPWpGaD
Deferoxamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000278	CcSEcCtD
Deferoxamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000277	CcSEcCtD
Deferoxamine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.73e-05	0.000276	CcSEcCtD
Deferoxamine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.73e-05	0.000276	CcSEcCtD
Deferoxamine—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000267	CcSEcCtD
Deferoxamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000258	CcSEcCtD
Deferoxamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000257	CcSEcCtD
Deferoxamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000249	CcSEcCtD
Deferoxamine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000247	CcSEcCtD
Deferoxamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.00024	CcSEcCtD
Deferoxamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000239	CcSEcCtD
Deferoxamine—Headache—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000236	CcSEcCtD
Deferoxamine—XDH—Metabolism—GNAS—peripheral nervous system neoplasm	7.34e-05	0.00294	CbGpPWpGaD
Deferoxamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.000231	CcSEcCtD
Deferoxamine—XDH—Metabolism—ABCB1—peripheral nervous system neoplasm	7.2e-05	0.00289	CbGpPWpGaD
Deferoxamine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000224	CcSEcCtD
Deferoxamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000222	CcSEcCtD
Deferoxamine—Headache—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000219	CcSEcCtD
Deferoxamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000207	CcSEcCtD
Deferoxamine—XDH—Metabolism—AKT1—peripheral nervous system neoplasm	1.98e-05	0.000795	CbGpPWpGaD
